What is the Global market size of the Central Nervous System Treatment Market?

Global Central Nervous System Treatment Market size was valued at USD 120.64 billion in 2021 and is poised to grow from USD 128.29 billion in 2022 to USD 209.2 billion by 2030, growing at a CAGR of 6.3% in the forecast period (2023-2030).

What is the key market trend for the Global Central Nervous System Treatment Market?

Improvements in Diagnosis and Therapeutics: The development of the therapeutics market for the central nervous system is being fuelled by improvements in diagnostics, therapies, and drug discovery approaches.

Central Nervous System Treatment Market Size, Share, Growth Analysis, By Disease Type(Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative diseases), By Drug class(Immunomodulatory drugs, interferons, Decarboxylase Inhibitors, Dopamine Agonists), By Drug Type(Biologics, Non-Biologics), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35B2179 | Region: Global | Published Date: February, 2024
Pages: 260 | Tables: 96 | Figures: 76

Central Nervous System Treatment Market Competitive Landscape

Central Nervous System Treatment Market Top Players Company Profiles

Pfizer Inc.
Novartis International AG
Johnson & Johnson
GlaxoSmithKline plc
Merck & Co., Inc.
AbbVie Inc.
Sanofi S.A.
Eli Lilly and Company
AstraZeneca plc
Biogen Inc.
Teva Pharmaceutical Industries Ltd.
UCB S.A.
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company
Ipsen S.A.
Lundbeck A/S
Otsuka Holdings Co., Ltd.
Sunovion Pharmaceuticals Inc.
Takeda Pharmaceutical Company Limited
Vertex Pharmaceuticals Incorporated

Central Nervous System Treatment Market

Central Nervous System Treatment Market Report Snapshots

Central Nervous System Treatment Companies

Central Nervous System Treatment Market Size

Central Nervous System Treatment Market Analysis

Central Nervous System Treatment Geographic Analysis

Central Nervous System Treatment Market News

License Type

File Type

$5,300
BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION

What is the market size of Central Nervous System Treatment Market?

Central Nervous System Treatment Market size was valued at USD 120.64 billion in 2019 and is poised to grow from USD 128.29 billion in 2023 to USD 209.2 billion by 2031, growing at a CAGR of 6.3% in the forecast period (2024-2031).

Who are the key vendors in the Central Nervous System Treatment Market?

Mergers, acquisitions, and partnerships are among the important market trends that are present. Major players in the market who are developing novel therapeutics for the treatment of disorders of the central nervous system have agreements with rival firms for distribution and research and development. For instance, Biogen and Sangamo Therapeutics reached an agreement to develop novel gene therapy medications for a range of neurological illnesses. The prospects of the CNS therapeutics market would be greatly improved by strategic actions implemented by leading businesses. 'Pfizer Inc.', 'Novartis International AG', 'Johnson & Johnson', 'GlaxoSmithKline plc', 'Merck & Co., Inc.', 'AbbVie Inc.', 'Sanofi S.A.', 'Eli Lilly and Company', 'AstraZeneca plc', 'Biogen Inc.', 'Teva Pharmaceutical Industries Ltd.', 'UCB S.A.', 'Boehringer Ingelheim International GmbH', 'Bristol-Myers Squibb Company', 'Ipsen S.A.', 'Lundbeck A/S', 'Otsuka Holdings Co., Ltd.', 'Sunovion Pharmaceuticals Inc.', 'Takeda Pharmaceutical Company Limited', 'Vertex Pharmaceuticals Incorporated'

What is the key driver of Central Nervous System Treatment Market?

The frequency and incidence of neurological illnesses, including multiple sclerosis, Alzheimer's disease, and Parkinson's disease, among others, are rapidly rising globally. In the upcoming years, the market's growth is expected to be significantly impacted by this increase. On the other side, countries with an increasing geriatric population are also experiencing an upsurge in the prevalence of Alzheimer's disease. For instance, the Alzheimer's Association estimates that more than five million people worldwide already suffer from Alzheimer's disease, and that figure is expected to increase to 14 million by the year 2050.

Which region accounted for the largest share in Central Nervous System Treatment Market?

By holding the greatest revenue share of 49.3%, North America dominated the market for CNS therapeutics. The presence of large corporations and efforts made by major medical organizations to create novel medicines for various central nervous system ailments are the factors anticipated to enhance the total market share.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Central Nervous System Treatment Market Competitive Landscape

Central Nervous System Treatment Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Central Nervous System Treatment Market Competitive Landscape

Central Nervous System Treatment Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Central Nervous System Treatment Market?

Who are the key vendors in the Central Nervous System Treatment Market?

What is the key driver of Central Nervous System Treatment Market?

What is the key market trend for Central Nervous System Treatment Market?

Which region accounted for the largest share in Central Nervous System Treatment Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300